Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Galapagos NV: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

29 Aug 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Galapagos NV (GLPG-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

04 Sep 2015 Thomson Reuters Stock Report 12 $25.00

ValuEngine Industry Report for Medical-Biomed/Genetics(GLPG)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

25 Aug 2015 ValuEngine, Inc. 10 $49.00

Galapagos NV (GLPG) - Financial Analysis Review

Galapagos NV (GLPG) - Financial Analysis Review Summary Galapagos NV (Galapagos) is a biotechnology company that develo...

14 Aug 2015 GlobalData 44 $125.00

Wright Investors Service Comprehensive Report for Galapagos NV

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

12 Aug 2015 Wright Reports 56 $75.00

GLPG.AS - Event Transcript of Galapagos NV conference call, Aug. 11, 2015 / 10:00AM ET

Edited Event Transcript of GLPG.AS conference call, Aug. 11, 2015 / 10:00AM ET Boston, Aug 11, 2015 (Thomson StreetEven...

11 Aug 2015 Thomson Reuters StreetEvents 13 $75.00

GLPG.AS - Event Transcript of Galapagos NV conference call, Aug. 06, 2015 / 8:00AM ET

Edited Event Transcript of GLPG.AS conference call, Aug. 06, 2015 / 8:00AM ET Boston, Sep 2, 2015 (Thomson StreetEvents...

06 Aug 2015 Thomson Reuters StreetEvents 9 $75.00

GLPG.AS - Event Transcript of Galapagos NV conference call, Jul. 30, 2015 / 10:00AM ET

Edited Event Transcript of GLPG.AS conference call, Jul. 30, 2015 / 10:00AM ET Boston, Jul 31, 2015 (Thomson StreetEven...

30 Jul 2015 Thomson Reuters StreetEvents 13 $75.00

Galapagos NV: An Alpha Deal Group Buy-Side Intelligence Brief

Galapagos NV (Galapagos) is a Belgian biotech company focusing on drug discovery using cells taken from patients with disease...

16 Jun 2015 Alpha Deal Group Intelligence Brief 6 $50.00

Is Galapagos NV Ready to Takeoff?

03 Jun 2015 Sadif Analytics Prime 12 $25.00